|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 24 5611-5620, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
S Iseki, AO Wilkie and GM Morriss-Kay
Department of Human Anatomy and Genetics, South Parks Road, Oxford OX1 3QX, UK.
Fibroblast growth factor receptors (FGFRs) play major roles in skeletogenesis, and activating mutations of the human FGFR1, FGFR2 and FGFR3 genes cause premature fusion of the skull bones (craniosynostosis). We have investigated the patterns of expression of Fgfr1, Fgfr2 and Fgfr3 in the fetal mouse head, with specific reference to their relationship to cell proliferation and differentiation in the frontal and parietal bones and in the coronal suture. Fgfr2 is expressed only in proliferating osteoprogenitor cells; the onset of differentiation is preceded by down-regulation of Fgfr2 and up-regulation of Fgfr1. Following up-regulation of the differentiation marker osteopontin, Fgfr1, osteonectin and alkaline phosphatase are down-regulated, suggesting that they are involved in the osteogenic differentiation process but not in maintaining the differentiated state. Fgfr3 is expressed in the cranial cartilage, including a plate of cartilage underlying the coronal suture, as well as in osteogenic cells, suggesting a dual role in skull development. Subcutaneous insertion of FGF2-soaked beads onto the coronal suture on E15 resulted in up-regulation of osteopontin and Fgfr1 in the sutural mesenchyme, down-regulation of Fgfr2, and inhibition of cell proliferation. This pattern was observed at 6 and 24 hours after bead insertion, corresponding to the timing and duration of FGF2 diffusion from the beads. We suggest (a) that a gradient of FGF ligand, from high levels in the differentiated region to low levels in the environment of the osteogenic stem cells, modulates differential expression of Fgfr1 and Fgfr2, and (b) that signalling through FGFR2 regulates stem cell proliferation whereas signalling through FGFR1 regulates osteogenic differentiation.
This article has been cited by other articles:
![]() |
L. Xiao, P. Liu, X. Li, T. Doetschman, J. D. Coffin, H. Drissi, and M. M. Hurley Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice J. Biol. Chem., January 30, 2009; 284(5): 3170 - 3182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Rawlins, C. R. Fernandez, M. E. Cozby, and L. A. Opperman Timing of Egf Treatment Differentially Affects Tgf-{beta}2 Induced Cranial Suture Closure Experimental Biology and Medicine, December 1, 2008; 233(12): 1518 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, N. Quarto, and M. T. Longaker Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1834 - C1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bouvard, A. Aszodi, G. Kostka, M. R. Block, C. Albiges-Rizo, and R. Fassler Defective osteoblast function in ICAP-1-deficient mice Development, July 15, 2007; 134(14): 2615 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, D. A. Scott, E. Hatch, X. Tian, and S. L. Mansour Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development Development, January 1, 2007; 134(1): 167 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. Xiao, F. Yang, B. O. Karim, A. J. Iacovelli, J. Cai, C. P. Lerner, J. T. Richtsmeier, J. M. Leszl, C. A. Hill, et al. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse Development, August 1, 2005; 132(15): 3537 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mansukhani, D. Ambrosetti, G. Holmes, L. Cornivelli, and C. Basilico Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation J. Cell Biol., March 28, 2005; 168(7): 1065 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Eswarakumar, M. C. Horowitz, R. Locklin, G. M. Morriss-Kay, and P. Lonai A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis PNAS, August 24, 2004; 101(34): 12555 - 12560. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. F. Twigg, R. Kan, C. Babbs, E. G. Bochukova, S. P. Robertson, S. A. Wall, G. M. Morriss-Kay, and A. O. M. Wilkie Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome PNAS, June 8, 2004; 101(23): 8652 - 8657. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valverde-Franco, H. Liu, D. Davidson, S. Chai, H. Valderrama-Carvajal, D. Goltzman, D. M. Ornitz, and J. E. Henderson Defective bone mineralization and osteopenia in young adult FGFR3-/- mice Hum. Mol. Genet., February 1, 2004; 13(3): 271 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics Development, January 15, 2004; 131(2): 325 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Reinhold, D. G. McEwen, and M. C. Naski Fibroblast Growth Factor Receptor 3 Gene: Regulation by Serum Response Factor Mol. Endocrinol., January 1, 2004; 18(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cowan, N. Quarto, S. M. Warren, A. Salim, and M. T. Longaker Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis J. Biol. Chem., August 22, 2003; 278(34): 32005 - 32013. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bobola, M. Carapuco, S. Ohnemus, B. Kanzler, A. Leibbrandt, A. Neubuser, J. Drouin, and M. Mallo Mesenchymal patterning by Hoxa2 requires blocking Fgf-dependent activation of Ptx1 Development, August 1, 2003; 130(15): 3403 - 3414. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, E. N. Olson, D. A. Towler, and D. M. Ornitz Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth Development, July 1, 2003; 130(13): 3063 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G. M. Morriss-Kay, and P. Lonai The IIIc alternative of Fgfr2 is a positive regulator of bone formation Development, March 10, 2003; 129(16): 3783 - 3793. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kim, J.-H. Kim, S.-C. Bae, J.-Y. Choi, H.-J. Kim, and H.-M. Ryoo The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2 J. Biol. Chem., January 3, 2003; 278(1): 319 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF] |
||||
![]() |
Z. Liu, J. Xu, J. S. Colvin, and D. M. Ornitz Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18 Genes & Dev., April 1, 2002; 16(7): 859 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes & Dev., April 1, 2002; 16(7): 870 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, M. Kobayashi, K. Matsumoto, T. Ogura, M. Nakafuku, and K. Shimamura Early subdivisions in the neural plate define distinct competence for inductive signals Development, January 1, 2002; 129(1): 83 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, R. P. Green, G. Zhao, and D. M. Ornitz Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains Development, October 1, 2001; 128(19): 3867 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lemonnier, E. Hay, P. Delannoy, O. Fromigue, A. Lomri, D. Modrowski, and P. J. Marie Increased Osteoblast Apoptosis in Apert Craniosynostosis : Role of Protein Kinase C and Interleukin-1 Am. J. Pathol., May 1, 2001; 158(5): 1833 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Hajihosseini, S. Wilson, L. De Moerlooze, and C. Dickson A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes PNAS, March 27, 2001; 98(7): 3855 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Greenwald, B. J. Mehrara, J. A. Spector, S. M. Warren, P. J. Fagenholz, L. P. Smith, P. J. Bouletreau, F. E. Crisera, H. Ueno, and M. T. Longaker In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate Am. J. Pathol., February 1, 2001; 158(2): 441 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome PNAS, December 19, 2000; 97(26): 14536 - 14541. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Zhou, X. Xu, L. Chen, C. Li, S. G. Brodie, and C.-X. Deng A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures Hum. Mol. Genet., August 12, 2000; 9(13): 2001 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)-Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Haraguchi, K Suzuki, R Murakami, M Sakai, M Kamikawa, M Kengaku, K Sekine, H Kawano, S Kato, N Ueno, et al. Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation Development, January 6, 2000; 127(11): 2471 - 2479. [Abstract] [PDF] |
||||